Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 12, 2023 16:05 ET | Source: IsoPlexis Corporation

IsoPlexis Reports Preliminary Full Year 2022 Revenue

BRANFORD, Conn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today...
December 21, 2022 16:49 ET | Source: IsoPlexis Corporation

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to Increase Profitability and Accelerate...
November 10, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis Reports Third Quarter 2022 Financial Results

BRANFORD, Conn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today...
November 09, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis to Participate in Upcoming Investor Conferences

BRANFORD, Conn., Nov. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today...
October 19, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

BRANFORD, Conn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today...
September 13, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform

BRANFORD, Conn., Sept. 13, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human...
September 06, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer Patients

BRANFORD, Conn., Sept. 06, 2022 (GLOBE NEWSWIRE) -- IsoPlexis (NASDAQ: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today announced a...
August 31, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference

BRANFORD, Conn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human...
August 23, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of Directors

BRANFORD, Conn., Aug. 23, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a company empowering labs to leverage the cells and proteome changing the course of human...
August 10, 2022 07:00 ET | Source: IsoPlexis Corporation

IsoPlexis Reports Second Quarter 2022 Financial Results

BRANFORD, Conn., Aug. 10, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering labs to leverage the cells and proteome changing the course of human health, today...